RA CAPITAL MANAGEMENT, L.P. sold 64.1% of their position (373.61K shares) of SIONNA THERAPEUTICS, INC. on the open market
Open‑market sale worth $14.76M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−14.12K
Price / share
$39.50
Trade value
$557.58K
% of position
Common Stock
Shares
−122.27K
Price / share
$39.50
Trade value
$4.83M
% of position
Common Stock
Shares
−66.67K
Price / share
$39.50
Trade value
$2.63M
% of position
Common Stock
Shares
−107.94K
Price / share
$39.50
Trade value
$4.26M
% of position
Common Stock
Shares
−3.62K
Price / share
$39.58
Trade value
$143.44K
% of position
Common Stock
Shares
−31.39K
Price / share
$39.58
Trade value
$1.24M
% of position
Common Stock
Shares
−17.12K
Price / share
$39.58
Trade value
$677.53K
% of position
Common Stock
Shares
−10.48K
Price / share
$39.58
Trade value
$414.64K
% of position
Net shares
−373.61K
Net value
-$14.76M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/24/2025 | S · Sale | −14.12K | $39.50 | $557.58K | 0.2% | 6.92M | 6.91M |
| Common Stock Indirect | 10/24/2025 | S · Sale | −122.27K | $39.50 | $4.83M | 14.1% | 869.65K | 747.38K |
| Common Stock Indirect | 10/24/2025 | S · Sale | −66.67K | $39.50 | $2.63M | 2.9% | 2.32M | 2.26M |
| Common Stock Indirect | 10/24/2025 | S · Sale | −107.94K | $39.50 | $4.26M | 32.9% | 327.81K | 219.87K |
| Common Stock Indirect | 10/28/2025 | S · Sale | −3.62K | $39.58 | $143.44K | 0.1% | 6.91M | 6.91M |
| Common Stock Indirect | 10/28/2025 | S · Sale | −31.39K | $39.58 | $1.24M | 4.2% | 747.38K | 715.99K |
| Common Stock Indirect | 10/28/2025 | S · Sale | −17.12K | $39.58 | $677.53K | 0.8% | 2.26M | 2.24M |
| Common Stock Indirect | 10/28/2025 | S · Sale | −10.48K | $39.58 | $414.64K | 4.8% | 219.87K | 209.39K |
| Total | −373.61K | -$14.76M | ||||||